Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2010 | 11-2009 | 11-2008 | 11-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 139,428 | -16,414 | -47,909 | 28,109 | N/A |
| Depreciation Amortization | 22,105 | 22,136 | 54,908 | 20,987 | N/A |
| Income taxes - deferred | N/A | 3,021 | 16,944 | -1,616 | N/A |
| Accounts receivable | -84,004 | 16,164 | -18,552 | -17,003 | N/A |
| Accounts payable and accrued liabilities | 59,178 | -14,909 | 15,249 | 11,150 | N/A |
| Other Working Capital | -95,884 | 24,920 | -44,604 | -14,558 | N/A |
| Other Operating Activity | 18,833 | 4,370 | 11,134 | 14,251 | 0 |
| Operating Cash Flow | $59,656 | $39,288 | $-12,830 | $41,320 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,328 | -15,453 | -25,763 | -16,974 | N/A |
| Net Acquisitions | -4,908 | N/A | N/A | -1,661 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -4,833 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -4,833 | 0 |
| Investing Cash Flow | $-25,236 | $-15,453 | $-25,763 | $-23,468 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,374 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -7,000 | N/A |
| Common Stock Issued | 2,113 | 87 | 2,044 | 2,905 | N/A |
| Common Stock Repurchased | N/A | N/A | -6,116 | N/A | N/A |
| Financing Cash Flow | $4,487 | $87 | $-4,072 | $-4,095 | $N/A |
| Beginning Cash Position | 51,935 | 28,013 | 70,678 | 56,921 | N/A |
| End Cash Position | 90,842 | 51,935 | 28,013 | 70,678 | N/A |
| Net Cash Flow | $38,907 | $23,922 | $-42,665 | $13,757 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 59,656 | 39,288 | -12,830 | 41,320 | N/A |
| Capital Expenditure | -20,328 | -15,453 | -25,763 | -16,974 | N/A |
| Free Cash Flow | 39,328 | 23,835 | -38,593 | 24,346 | 0 |